The prevalence of erectile dysfunction and its associated factors among diabetic patients in the Southwestern Region of Saudi Arabia analytical cross-sectional study

Background: Erectile dysfunction (ED) is a common condition among diabetic patients, significantly affecting their quality of life. This study examines the prevalence of ED and the factors contributing to its occurrence among diabetic patients in the southwestern region of Saudi Arabia. Methods: This analytical cross-sectional study was conducted in randomly selected Primary Healthcare Centers (PHCCs) across the Asir region. The sample included 398 married male Saudi nationals aged 18 years and older, diagnosed with diabetes and attending PHCCs. Data collection involved a standardized questionnaire that included the International Index of Erectile Function (IIEF-5) to measure ED severity and explore related factors. Statistical analysis was performed using SPSS v22, with descriptive statistics including Chi-square tests, independent t-tests, analysis of variance (ANOVA) and multiple regression. Results: Most participants were aged 41–60 years (51.5%), with 55.5% having completed high school or bachelor’s education and 67.8% earning an income of ≤10,000 SR. Most participants (82.9%) have Type 2 diabetes and 21.9% reported smoking. Clinical findings revealed a mean body mass index (BMI) of 28.53, glycemic control was poor, with only 29.1% achieving controlled hemoglobin A1C (HbA1C), while 18.3% had severely uncontrolled levels. In terms of ED severity, mild to moderate dysfunction was most common (29.6%), followed by mild dysfunction (25.1%) and moderate dysfunction (20.4%). Severe dysfunction affected 13.1%, while 11.8% reported no dysfunction. Significant correlations were observed between ED severity and factors such as age, education level, income, duration of diabetes and HbA1C levels (p < 0.05). Smoking status was also significantly associated with ED severity (p = 0.0116), while BMI showed no significant correlation (p = 0.791). Conclusions: Erectile dysfunction is prevalent among diabetic patients in the Asir region, with its severity influenced by demographic and clinical factors. Younger age, higher education, and better glycemic control were associated with reduced ED severity.

Erectile dysfunction; Diabetes; Prevalence; Predictors; Saudi Arabia; Glycemic control

[1] Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, et al. Erectile dysfunction and diabetes: a melting pot of circumstances and treatments. Diabetes/Metabolism Research and Reviews. 2022; 38: e3494.

[2] Mazzilli R, Zamponi V, Olana S, Mikovic N, Cimadomo D, Defeudis G, et al. Erectile dysfunction as a marker of endocrine and glycemic disorders. Journal of Endocrinological Investigation. 2022; 45: 1527–1534.

[3] Dilixiati D, Waili A, Tuerxunmaimaiti A, Tao L, Zebibula A, Rexiati M. Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis. Frontiers in Endocrinology. 2024; 15: 1368079.

[4] Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World Journal of Diabetes. 2014; 5: 444–470.

[5] Mukhtar Y, Galalain A, Yunusa U. A modern overview on diabetes mellitus: a chronic endocrine disorder. European Journal of Biology. 2020; 5: 1–14.

[6] Abdulaziz Al Dawish M, Alwin Robert A, Braham R, Abdallah Al Hayek A, Al Saeed A, Ahmed Ahmed R, et al. Diabetes mellitus in Saudi Arabia: a review of the recent literature. Current Diabetes Reviews. 2016; 12: 359–368.

[7] Robert AA, Al Dawish MA, Braham R, Musallam MA, Al Hayek AA, Al Kahtany NH. Type 2 Diabetes mellitus in Saudi Arabia: major challenges and possible solutions. Current Diabetes Reviews. 2017; 13: 59–64.

[8] El Bcheraoui C, Basulaiman M, Tuffaha M, Daoud F, Robinson M, Jaber S, et al. Status of the diabetes epidemic in the Kingdom of Saudi Arabia, 2013. International Journal of Public Health. 2014; 59: 1011–1021.

[9] Ahmed AAB, Alruwaili MN, Alanazi JF, Alanazi DF, Alanazi AS. Awareness of diabetic patients regarding diabetes complications in Saudi Arabia: systematic review. Pharmacophore. 2022; 13: 58–63.

[10] AlMogbel TA. Erectile dysfunction and other sexual activity dysfunctions among Saudi type 2 diabetic patients. International Journal of Health Sciences. 2014; 8: 347–359.

[11] Almigbal TH, Schattner P. The willingness of Saudi men with type 2 diabetes to discuss erectile dysfunction with their physicians and the factors that influence this. PLOS ONE. 2018; 13: e0201105.

[12] Ewid M, Algoblan AS, Elzaki EM, Muqresh MA, Al Khalifa AR, Alshargabi AM, et al. Factors associated with glycemic control and diabetes complications in a group of Saudi patients with type 2 diabetes. Medicine. 2023; 102: e35212.

[13] Ibrahim FM, Rashad Dabou EA, AbdelSamad S, Abuijlan IAM. Prevalence of bullying and its impact on self-esteem, anxiety and depression among medical and health sciences university students in RAS Al Khaimah, UAE. Heliyon. 2024; 10: e25063.

[14] Irfan M, Hussain NHN, Noor NM, Mohamed M, Sidi H, Ismail SB. Epidemiology of male sexual dysfunction in Asian and European regions: a systematic review. American Journal of Men’s Health. 2020; 14: 1557988320937200.

[15] Mahzari M, Alhamlan KS, Alhussaini NA, Alkathiri TA, Al Khatir AN, Alqahtani AM, et al. Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center. Annals of Saudi Medicine. 2022; 42: 334–342.

[16] Zhang X, Yang B, Li N, Li H. Prevalence and risk factors for erectile dysfunction in Chinese adult males. The Journal of Sexual Medicine. 2017; 14: 1201–1208.

[17] Alzahrani F, Madkhali OA, Khardali A, Alqahtani SS, Hijri AM, Alaqil MA, et al. Awareness and prevalence of self-reported benign prostatic hyperplasia: a cross-sectional study in Saudi Arabia. Frontiers in Public Health. 2024; 12: 1271816.

[18] AF, GamalEl Din SF. Study of the risk factors of erectile dysfunction and phospho diestrase type 5 inhibitors usage among Egyptian population with erectile dysfunction: a cross-sectional survey. Revista Internacional de Andrología. 2021; 19: 249–258.

[19] Tamayo T, Rosenbauer J, Wild SH, Spijkerman AM, Baan C, Forouhi NG, et al. Diabetes in Europe: an update. Diabetes Research and Clinical Practice. 2014; 103: 206–217.

[20] Kessler A, Sollie S, Challacombe B, Briggs K, Van Hemelrijck M. The global prevalence of erectile dysfunction: a review. BJU International. 2019; 124: 587–599.

[21] Weinberg AE, Eisenberg M, Patel CJ, Chertow GM, Leppert JT. Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction. The Journal of Sexual Medicine. 2013; 10: 3102–3109.

[22] Salonia A, Castagna G, Saccà A, Ferrari M, Capitanio U, Castiglione F, et al. Is erectile dysfunction a reliable proxy of general male health status? The case for the international index of erectile function-erectile function domain. The Journal of Sexual Medicine. 2012; 9: 2708–2715.

[23] Powers MA, Bardsley JK, Cypress M, Funnell MM, Harms D, Hess-Fischl A, et al. Diabetes self-management education and support in adults with type 2 diabetes: a consensus report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. Journal of the American Pharmacists Association. 2020; 60: e1–e18.

[24] Dawoud SO, Ahmad AM, Alsharqi OZ, Al-Raddadi RM. Utilization of the emergency department and predicting factors associated with its use at the Saudi Ministry of Health General Hospitals. Global Journal of Health Science. 2015; 8: 90–106.

[25] Gutiérrez OM, Anderson C, Isakova T, Scialla J, Negrea L, Anderson AH, et al. Low socioeconomic status associates with higher serum phosphate irrespective of race. Journal of the American Society of Nephrology. 2010; 21: 1953–1960.

[26] Tecce N, Menafra D, Proganò M, Tecce MF, Pivonello R, Colao A. Evaluating the impact of continuous glucose monitoring on erectile dysfunction in type 1 diabetes: a focus on reducing glucose variability and inflammation. Healthcare. 2024; 12: 1823.

[27] Gryzinski GM, Fustok J, Raheem OA, Bernie HL. Sexual function in men undergoing androgen deprivation therapy. Androgens: Clinical Research and Therapeutics. 2022; 3: 149–158.

[28] Yuan C, Jian Z, Gao X, Jin X, Wang M, Xiang L, et al. Type 2 diabetes mellitus increases risk of erectile dysfunction independent of obesity and dyslipidemia: a mendelian randomization study. Andrology. 2022; 10: 518–524.

[29] Charlton A, Garzarella J, Jandeleit-Dahm KAM, Jha JC. Oxidative stress and inflammation in renal and cardiovascular complications of diabetes. Biology. 2020; 10: 18.

[30] Huang H, Dong M, Zhang L, Zhong B, Ng CH, Ungvari GS, et al. Psychopathology and extrapyramidal side effects in smoking and non-smoking patients with schizophrenia: systematic review and meta-analysis of comparative studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019; 92: 476–482.

[31] Walicka M, Krysiński A, La Rosa GRM, Sun A, Campagna D, Di Ciaula A, et al.; DiaSmokeFree Working Group. Influence of quitting smoking on diabetes-related complications: a scoping review with a systematic search strategy. Diabetes & Metabolic Syndrome. 2024; 18: 103044.

[32] Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go? Journal of Diabetes Investigation. 2011; 2: 18–32.

[33] Patel SA, Ali MK, Alam D, Yan LL, Levitt NS, Bernabe-Ortiz A, et al. Obesity and its relation with diabetes and hypertension: a cross-sectional study across 4 geographical regions. Global Heart. 2016; 11: 71–79.e4.

[34] Geerkens MJM, Al-Itejawi HHM, Nieuwenhuijzen JA, Meuleman EJM, Lissenberg-Witte BI, van Moorselaar RJA, et al. Sexual dysfunction and bother due to erectile dysfunction in the healthy elderly male population: prevalence from a systematic review. European Urology Focus. 2020; 6: 776–790.

[35] Goulding JM, Price CL, Defty CL, Hulangamuwa CS, Bader E, Ahmed I. Erectile dysfunction in patients with psoriasis: increased prevalence, an unmet need, and a chance to intervene. The British Journal of Dermatology. 2011; 164: 103–109.